Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pragmatic Randomised Control Trial of Quetiapine for Psychosis in Parkinson's Disease
2004-002608-13Phase 4Completed
- Sponsor
- King's College London
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of quetiapine in Parkinson's disease (PD) (2 arms), sponsored by King's College London. Primary endpoints: Psychosis symptoms score and Time remaining in the trial. Started Apr 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-002608-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002608-13.